U.S. Food and Drug Administration, Center for Drug Evaluation and Research
FDA Drug Safety Podcasts
Mantenha-se informado com discussões perspicazes sobre atualizações de segurança de medicamentos e comunicações da FDA, ajudando você a tomar melhores decisões para sua saúde e bem-estar.
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
5 mins • Jan 2, 2025
Charts
This show is not currently ranked in any charts.
Episódios recentes
Jan 2, 2025
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
5 mins
Sep 20, 2024
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause
4 mins
Feb 6, 2024
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)
4 mins
Jan 26, 2024
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
4 mins
Dec 8, 2023
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
5 mins
Idioma
Inglês
País
Austrália
Website
Feed